Downtown life sciences corridor flagged for development
A new task force is charged with making recommendations for development of the city’s downtown certified technology
park.
Life Science & Biotech
Articles
Zimmer offering seeks $1B
The Indiana-based orthopedic implant maker plans to use the proceeds to pay down debt and for general corporate purposes.
Aarden Pharmaceuticals chose Indianapolis over San Diego for headquarters
Thanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided
locating here would give Aarden a better chance of success.
FDA questions role of payments in Zimmer study
Federal health officials say an implant from Indiana-based Zimmer Holdings Inc. appears to be effective in treating spinal
problems, but questions remain about whether company payments to doctors influenced the device’s trial data.
Indiana among 15 states accusing Amgen of illegal kickbacks
Biotechnology behemoth Amgen Inc. is being sued by 15 states, including Indiana, alleging the company gave kickbacks to medical
providers to help boost sales of the Aranesp.
Lilly opens new biotech center in San Diego
Lilly is opening the San Diego biotech center a year after launching a biotech R&D center in Indianapolis.
Pace of life sciences venture capital deals in Indiana picks up
After no Indiana health and life sciences firms announced venture capital deals in the second quarter, five did so in the
third, and two more have already this month.
TechPoint to focus on IT firms specializing in medical, life sciences sectors
Long tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
Indianapolis-based FAST Diagnostics gets funding from BioCrossroads’ seed fund
Money will help the company refine its tool to treat acute kidney injury.
Dow AgroSciences’ revenue, profit fall on lower crop prices
Dow AgroSciences, the local subsidiary of Midland, Mich.-based Dow Chemical Co., said Thursday that revenue fell 20 percent
and profits plummeted in the third quarter due largely to lower crop commodity prices.
Zimmer profits fall, but beat expectations
The Warsaw-based company recorded a third-quarter profit of $150 million, down 30 percent from the same quarter a year ago.
Cook: Tax could kill 1,000 jobs in Bloomington
Bloomington-based Cook Group Inc. could find itself cutting as many as 1,000 local jobs if Congress enacts a tax on
medical devices to pay for health care reform, company founder Bill Cook said in an interview.
State’s health IT groups seek stimulus funds
Some of Indiana’s leading organizations in health information technology are collaborating on an effort to receive several
million dollars of stimulus funding.
Purdue gets $1M for plant-climate research
The U.S. Department of Agriculture has given Purdue University a nearly $1 million grant to study ways that genomics can be
used to enhance the value of certain plants while making them more resilient to climate stress.
Dow AgroSciences ratcheting up biotech efforts
Dow AgroSciences’ introduction of a promising new product is helping transform the Indianapolis company as it transitions
from a focus on traditional agricultural chemicals to genetically altered seeds. The subsidiary of Michigan-based Dow Chemical
Co. partnered with St. Louis-based Monsanto Co. to develop what could become its biggest blockbuster, a genetically modified
corn variety it calls SmartStax.
Indiana life sciences leaders discover dozens of tiny outsourcing companies
BioCrossroads, an Indianapolis-based not-for-profit, is cataloging Indiana businesses offering contract services to pharmaceutical
and biotechnology companies, and discovering many small firms operating in relative obscurity.
Dow AgroSciences and the Holy Grail
Dow AgroSciences could boost its market share in genetically altered corn almost overnight by inventing a perennial corn.
But investors might not have the patience.
Dow Agro to become Purdue research tenant
Officials of Purdue University and Dow AgroSciences unveiled a collaboration Wednesday in which the Indianapolis-based company
will become one of the largest tenants at the Purdue Research Park in West Lafayette.
Lilly’s win in Evista patent case crucial, analyst says
A decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.’s Evista marks a major
victory for the company, says an analyst who closely follows the pharmaceutical industry.
Judge upholds Lilly’s Evista patent
A federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.’s drug Evista, the company announced
late yesterday.